(Q39410303)

English

Characterization of glioma stem cells through multiple stem cell markers and their specific sensitization to double-strand break-inducing agents by pharmacological inhibition of ataxia telangiectasia mutated protein

scientific article published on 21 February 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Characterization of glioma stem cells through multiple stem cell markers and their specific sensitization to double-strand break-inducing agents by pharmacological inhibition of ataxia telangiectasia mutated protein (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1 reference

based on heuristic

inferred from title

ataxia telangiectasia

1 reference

based on heuristic

inferred from title

Alessandro Poggi

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

author name string

Alessandro Raso

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Donatella Vecchio

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Enrico Cappelli

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Monica Ropolo

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Paolo Nozza

6

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Roberto Biassoni

7

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Samantha Mascelli

8

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Valeria Capra

9

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Fotios Kalfas

10

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Paolo Severi

11

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Guido Frosina

12

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

21 February 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Brain Pathology

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

677-688

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

BMI1 sustains human glioblastoma multiforme stem cell renewal

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00566.X

21 January 2018

Checkpoint kinase inhibitors: SAR and radioprotective properties of a series of 2-arylbenzimidazoles

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00566.X

21 January 2018

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00566.X

21 January 2018

The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00566.X

21 January 2018

Recent advances in cancer therapy targeting proteins involved in DNA double-strand break repair.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00566.X

21 January 2018

The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00566.X

21 January 2018

CHK1 inhibition as a strategy for targeting Fanconi Anemia (FA) DNA repair pathway deficient tumors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00566.X

21 January 2018

DNA repair and resistance of gliomas to chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00566.X

21 January 2018

Frontiers in targeting glioma stem cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00566.X

21 January 2018

Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00566.X

21 January 2018

Inconsistent immunohistochemical expression patterns of four different CD133 antibody clones in glioblastoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00566.X

21 January 2018

Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00566.X

21 January 2018

A new mathematical model for relative quantification in real-time RT-PCR

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00566.X

21 January 2018

Successful isolation and long-term establishment of a cell line with stem cell-like features from an anaplastic medulloblastoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00566.X

21 January 2018

High levels of PROM1 (CD133) transcript are a potential predictor of poor prognosis in medulloblastoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00566.X

21 January 2018

Comparative analysis of DNA repair in stem and nonstem glioma cell cultures

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00566.X

21 January 2018

ZNF238 is expressed in postmitotic brain cells and inhibits brain tumor growth

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00566.X

21 January 2018

Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00566.X

21 January 2018

Uncommon cytogenetic findings in a case of splenic marginal zone lymphoma with aggressive clinical course

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00566.X

21 January 2018

Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00566.X

21 January 2018

Identifiers

10.1111/J.1750-3639.2012.00566.X

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39410303&oldid=1826356440"